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Abstract
Background: Gap junctions (GJs) are intercellular channels through which molecules smaller than 1 kDa can diffuse,
and they have been suggested as drug targets. To develop chemical drugs acting on this target, a high-throughput
screening (HTS) system for GJ modulators is necessary.
Results: We designed a new, high-throughput GJ intercellular communication (GJIC) assay. This assay system consisted
of donor and acceptor cells from LN215 glioma cells that expressed SLC26A4 and yellow fluorescent protein-H148Q/
I152L (YFPQL), respectively. The fluorescence of LN215-YFPQL acceptor cells, when cultured alone, was not
quenched by iodide. However when donor and acceptor cells, or LN215-YFPQL and LN215-I− cells, were mixed
and plated, they formed GJs. When iodide was added, it was transported into donor cells by SLC26A4, diffused
through the GJs to acceptor cells, and quenched the YFPQL fluorescence. The quenching rate was optimal at a
2:1 mixture of donor and acceptor cells. The assay quality parameter, Z’ factor, was calculated from data collected with
vehicle and carbenoxolone. For each assay, the Z’ factor increased with time. The Z’ factor of a 10-s assay was 0.72
indicating that the assay quality was high enough for use in HTS. This assay system also worked well in HOS
osteosarcoma cells with a Z’ factor at 10 s of 0.70.
Conclusions: We developed a new HTS system for GJ modulators. The system had a high assay quality with a
Z’ factor ≥ 0.70, was rapid and required only 10 s per well, was inexpensive in requiring no additional reagents,
and was predicted to have a low rate of false-positive hits.
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Background
Gap junctions (GJs) are intercellular channels that allow
diffusion of small molecules (<1 kDa) including nutri-
ents, metabolites, and signalling molecules such as
cAMP, Ca2+, and IP3 [1]. Six connexins form a tube-like
structure called a connexon, which works as a hemi-
channel that opens to the extracellular space or can dock
to another connexon on a neighbouring cell, forming a
GJ. The human connexin family contains 21 connexin
proteins named for their molecular weights [2].
The functional importance of connexins is substanti-
ated by various diseases that are caused by mutations in
connexin genes. Mutations in GJB2, which encodes
human connexin26, lead to syndromic hearing loss with
skin symptoms or non-syndromic hearing loss [3]. Dis-
ruptions of connexin43 by mutations in GJA1 result in
oculodentodigital dysplasia causing multiple develop-
mental abnormalities [4].
There is also evidence that GJ is a pharmacologic tar-
get in disease. GJs play a crucial role in propagating car-
diac muscle contractions. Thus, GJ modulators have
therapeutic efficacy for arrhythmia. AAP, a naturally
occurring anti-arrhythmic peptide, exerts its activity
by enhancing GJ [5]. Its orally-active derivative,
GAP134, prevents post-operative atrial fibrillation. GJs
can spread cell death signals or harmful molecules
from cells in a damaged area to relatively healthy cells
and, thus, aggravate tissue damage. A GJ inhibitor, 2-
aminoethoxydiphenyl borate (2-APB), was shown to pro-
tect against liver damage caused by hepatotoxic drugs [6].
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Pharmacologic inhibition of the connexin43 hemichannel
with Gap26 protects cardiomyocytes in vivo [7]. The
therapeutic effects of bisphosphonates on osteoporosis are
partially due to their anti-apoptotic effects mediated by
binding to the connexin43 hemichannel [8].
To assess GJ activity, dye transfer-based methods have
been used [9]. Lucifer yellow is frequently used as a GJ-
permeable fluorescent dye and is introduced into cells
by microinjection [10], scrape loading [11], or electro-
poration [12]. GJ activity is determined by quantifying
diffusion of the dye into cells without the dye. Another
dye, calcein-AM (acetoxymethyl ester) has been used for
a fluorescence recovery after photobleaching assay [13].
In this assay, cells are preloaded with calcein-AM before
cells of interest are bleached with a high-power laser
beam. Calcein diffusion from non-bleached cells to
bleached cells is measured by time-lapse confocal imaging.
Another method to assess GJ activity is measurement of
junctional conductance using a dual patch clamp. In con-
trast to dye transfer, it has high sensitivity and high tem-
poral resolution. However, because micropipettes are
inserted into two adjacent cells, and the surfaces are
sealed before measuring junctional conductance, the dual
patch clamp method is technically demanding and time-
consuming [9]. To develop drugs targeting GJ, a high-
throughput screening (HTS)-compatible assay system is
needed. However applying the methods described above
to HTS is practically impossible.
Here we developed and report a simple, inexpensive,
rapid, robust (shown by Z’ factor), and HTS-compatible
GJIC assay.
Results
Design of I−-YFPQL GJIC assay
We designed a new GJ intercellular communication
(GJIC) assay that used two types of cells (Fig. 1). Donor
Fig. 1 The scheme of I−-YFPQL GJIC assay. Black and yellow rectangles represent donor cells expressing an iodide transporter, SLC26A4, and acceptor
cells with YFPQL. Blue and red parallel lines indicate gap junctions and iodide transporters, respectively. Acceptor cells were impermeable to iodide.
Added iodide could only reach acceptor cells by passing through the iodide transporter in the donor cells and then through the gap junction
between donor and acceptor cells. The YFPQL in acceptor cells was quenched by the iodide
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cells expressed a membrane protein capable of trans-
porting extracellular iodide into cells. Acceptor cells
expressed an iodide sensor protein, yellow fluorescent
protein H148Q/I152L (hereafter YFPQL) [14]. When iod-
ide was added to a co-culture of the two cells, whose cy-
tosols were connected by GJs, the iodide entered the
donor cells, passed through the GJs to acceptor cells,
and quenched the fluorescence of YFPQL. If GJs were ab-
sent or closed, the added iodide diffused into donor cells
but not acceptor cells, and YFPQL fluorescence did not
change.
I−-YFPQL GJIC assay in the co-culture of LN215-I− and
LN215-YFPQL
To generate cells expressing enough iodide transporter
or YFPQL, we produced lentiviruses expressing SLC26A4
or YFPQL. LN215, a human glioma cell, was chosen as
the target cell type because astrocytes and glioma cells
express functional GJs [15]. We also confirmed through
immunoblotting that LN215 cells express connexin43
(Additional file 1). We generated LN215-I− donor cells
and LN215-YFPQL acceptor cells through lentiviral
transduction followed by antibiotic selection. LN215-
YFPQL cells combined with wild-type LN215 cells or
LN215-I− cells were plated on 96-well plates 24 h before
the assay. Culture media were changed to C-solution, a
balanced salt solution without iodide, and fluorescence
images were collected before and 1 min after adding I-
solution, a balanced salt solution containing 140 mM
iodide. As shown in Fig. 2a, the YFPQL fluorescence of
wells containing wild-type LN215 and LN215-YFPQL
cells did not decrease 1 min after addition of I-solution.
Conversely, the fluorescence of the wells with LN215-I−
and LN215-YFPQL cells decreased when iodide was
added (Fig. 2b). These results suggest that iodide did not
enter LN215-YFPQL cells directly; however, when
LN215-I− donor and LN215-YFPQL acceptor cells were
plated in the same well, iodide entered LN215-I− and
traveled through GJs to LN215-YFPQL.
Optimizing the I−-YFPQL GJIC assay
To determine the optimal ratio of donor and acceptor
cells for the GJIC assay, we plated 0:6, 1:5, 1:2, 1:1, 2:1,
5:1, and 6:0 mixtures of donor and acceptor cells before
the GJIC assay. The mean fluorescence intensities of
wells with donor cells only (6:0) at each time point were
subtracted from fluorescence intensities of the other
groups at the corresponding time point before calcu-
lation of % YFP fluorescence. As shown in Fig. 3a,
the fluorescence of wells with acceptor cells only (0:6)
did not decrease when iodide was added. The fluores-
cence of wells with mixed cells decayed with time
after adding iodide. The final quenching rates were
shown as a bar graph (Fig. 3b). The larger was the
Fig. 2 Fluorescence image of I−-YFP GJIC assay in LN215 cells. The LN215-YFPQL cells combined with wild-type LN215 (a) or LN215-I- (b) cells were
plated on a 96-well plate. After 24 h of incubation, the culture media were replaced with 100 μL of C-solution. Phase contrast and fluorescence
images were collected before and 1 min after adding 100 μL of I-solution. For the composition of the C- and I-solutions, see the I−-YFPQL GJIC
assay in the Methods section
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number of donor cells plated, the higher was the final
quenching rate (GJIC activity). The quenching rates
of neighboring two groups were significantly different
(p < 0.05, Student’s t-test) except when 2:1 (48.3 ± 2.3 %,
mean ± standard deviation) and 5:1 (54.8 ± 1.7 %) were
compared. The 5:1 ratio might be better for obtaining
a strong signal, but it takes more time to cultivate
the number of cells needed to plate the two types of
cells at 5:1 compared to that needed at 2:1. Thus for
convenience, a 2:1 ratio of donor and acceptor cells
was used in the later GJIC assays. The 10-s % YFP
quenching with or without background subtraction
was 48.3 and 42.1 %, respectively. Hence, to simplify
data processing, background subtraction was omitted
in the following data analysis. The raw fluorescence
values (Additional file 2) without background subtrac-
tion or normalization to the starting points were also
plotted against time and are presented as Additional
file 3.
Performance of the I−-YFPQL GJIC assay
To assess the performance of the LN215-I−/LN215-
YFPQL system as an HTS GJIC assay, we measured
the effects of vehicle (water) and carbenoxolone
(CBX), a widely used GJ inhibitor, on GJ activity as
quantified by percent YFPQL quenching. CBX was ap-
plied at 25 μM, at which concentration a 30-min
treatment was not toxic to LN215 cells (data not
shown) and GJIC was completely inhibited [16]. The
quenching rates of all well at 10 s were plotted
against well number and are shown in Fig. 4a. The
mean ± standard deviation of vehicle and the CBX
groups were 42.9 ± 1.8 and 7.3 ± 1.3 %, respectively.
The Z’ factor has been used as an assay quality indi-
cator, reflecting the signal window between positive
and negative controls [17]. Z’ factors were calculated
from % YFP quenching at 4, 6, 8… 20 s and plotted
against assay time. As the assay was prolonged, the
YFP quenching rates increased and the quality param-
eters also increased from 0.54 at 4 s to 0.81 at 20 s.
Because an HTS assay with a Z’ factor higher than
0.5 is considered acceptable, the I−-YFPQL GJIC assay
is robust enough to be used in an HTS [17]. In
addition, to verify that the reduced quenching by
CBX was the result of reduced GJ coupling rather
than a direct effect of the drug itself, only LN215-
YFPQL cells or a 2:1 mixture of LN215-I− and LN215-
YFPQL cells were plated 24 h before treatment with
vehicle or 25 μM CBX for 10 min. Then, the I−-YFPQL
assay was performed for 10 s. The % YFP fluorescence
was plotted against time and is shown in Additional
file 4. When only the acceptor cells were plated, the
CBX treatment did not produce a significant change in
YFP fluorescence, which supported the supposition
that CBX reduction in YFP quenching is due to its in-
hibition of GJs.
To assess the sensitivity of the I−-YFPQL assay as a
screening tool for GJIC modulator, we applied CBX to
the mixed cultures at 0, 1, 1.3, 1.7, 2.3, 3 and 10 μM
diluted in C-solution for 10 min before the I−-YFPQL
GJIC assay. These results are shown in Fig. 4c. The
IC50 value for CBX was 2.1 μM with a 95 % confi-
dence interval of 2.0–2.2 μM, which was similar to a
Fig. 3 Determination of the optimal ratio of donor and acceptor
cells. LN215-I- and LN215-YFPQL cells were mixed and plated on
96-well plates at ratios of 0:6, 1:5, 1:2, 1:1, 2:1, 5:1 and 6:0 and
incubated for 24 h. After culture media were replaced with 100 μL of
C-solution, the plate was inserted into the multi-plate reader. The YFPQL
fluorescence of each well was read every 0.4 s for 10 s. One second
after the first measurement, 100 μL of I-solution was added by the
automatic injector in the plate reader. Assay of each group was
performed in three wells. The mean fluorescence intensity of the
6:0 group at each time point was considered as background and
subtracted from fluorescence intensities of the other groups at
the corresponding time point. Then, the relative YFP fluorescence at
each time was normalized to the fluorescence of the starting point
and plotted against time. Error bars represent standard deviations (a).
The percent final YFP quenching was calculated and expressed as
mean ± standard deviation (b). *, p < 0.05 (Student t-test)
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previous report [16]. We measured the effects of 40
known chemicals at concentrations of 25 μM on GJIC
activity using this screening system. One chemical, 2-
APB, was found to act as a GJ inhibitor (Fig. 4d).
The tested chemicals are listed in Additional file 5.
Applying the I−-YFPQL GJIC assay to another cell type
To determine whether this GJIC assay was applicable
to other cell types, HOS human osteosarcoma cells
were chosen due to their expression of connexin43
(Additional file 1). As in the LN215-I−/LN215-YFPQL
system, a 2:1 mixture of HOS-I− and HOS-YFPQL
cells was plated 24 h before treatment with vehicle or
25 μM CBX. Each group contained 48 wells treated
for 10 min. The I−-YFPQL assay was performed well
by well. The percent YFP quenching at 10 s is shown
in Fig. 5. The Z’ factor was 0.70.
Discussion
In 2003, Aventis published an HTS system for a GJ
modulator [18] using a high content screening system.
They co-plated donor cells preloaded with calcein-AM
and receptor cells on multi-well plates and chased the
fluorescence image of each well. Calcein diffusion from
donor cells to neighboring receptor cells was quantified
by specialized image analysis software. Although calcein-
AM used in GJIC assay becomes cell-impermeable after
its acetomethoxy group is removed by intracellular ester-
ases, calcein can be actively pumped out by multidrug
resistance protein 1 [19]. Thus, donor cells should be
preloaded with calcein-AM, and donor and acceptor
cells should be detached, mixed and plated, treated with
drug, and incubated to allow for dye diffusion through
the GJs with time-lapse imaging sequentially without
pause. This long, laborious method is difficult to schedule
and is error-prone. Cells that need a long time to attach to
Fig. 4 Performance of I−-YFP GJIC assay as a HTS system. To assess the quality of the I−-YFP GJIC HTS assay, a 2:1 mixture of LN215-I- and LN215-YFPQL
cells was plated on a 96-well plate. After 24 h of cultivation, vehicle (water) or 25 μM of CBX diluted in C-solution was added to the well for 10 min,
with each treatment being applied to 48 wells. To investigate the effect of assay time on Z’ factor, the I−-YFP assay was conducted for 20 s per well.
The percent YFP quenching at 4, 6, 8,…, and 20 s was calculated. The values at 10 s were plotted against well number (a). Z’ factors were calculated
using positive (CBX) and negative (vehicle) control data at each time point, as described in the Methods section, and the results were plotted against
assay time. Pearson’s correlation coefficient was calculated in Microsoft Excel 2010 using Pearson’s function, which was 0.887 (b). The mixed cultures
were treated with CBX at 0, 1, 1.3, 1.7, 2.3, 3 and 10 μM in C-solution for 10 min before the GJIC assay. Each treatment was added to five wells. The
mean % YFP fluorescence was plotted against time. Error bars represent standard deviations. The IC50 for GJIC activity by CBX was calculated with
GraphPad Prism 4 (GraphPad Software) (c). The 40 chemicals listed in Additional file 5 were applied to the mixed cultures before the GJIC assay. All
chemicals were applied at a concentration of 25 μM. The % YFP quenching at 10 s was plotted against chemical number. All GJIC activities were within
the range of the mean ± standard deviation except when 2-APB was applied (d)
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the culture surface and form GJs are not appropriate for
this assay system. Recently another HTS system for GJ
modulators was developed by GlaxoSmithKline R&D [20].
They measured the propagation of cellular calcium signal
using a Ca2+-sensitive, bioluminescent protein, aequorin.
This assay system also used donor and acceptor cells.
Donor cells were engineered to express the adrenergic α1
receptor or TrpV1 ion channel to generate a calcium sig-
nal. This system quantifies light emitted from acceptor
cells, which express codon-optimized aequorin. The
aequorin prosthetic group, coelenterazine, must be added
to culture. Assaying the propagation of a calcium signal,
an important physiological event mediated by GJ, is a
strong benefit of this system. However, it can also be a
drawback because any modulator of calcium signalling
can be detected, most of which may be false positives. The
adrenergic α1 receptor or TrpV1 channel can also cause
false positives.
We developed an improved HTS for GJ modulators.
An iodide transporter, SLC26A4, and a highly sensitive
iodide sensor, YFPQL, were expressed by lentiviral vec-
tors in donor and acceptor cells, respectively. Iodide
transport from donor to acceptor cells via GJs was mea-
sured by YFPQL quenching. While coelenterazine, a
prosthetic group of aequorin is necessary for the
aequorin assay, no additional reagent is needed for the
YFPQL fluorometry, which lowers the cost of this assay.
Another merit of I−-YFPQL assay is the short assay time.
When we used LN215 or HOS cells, 10 s was enough to
achieve excellent assay performance. Furthermore if the
Z’ factor of the I−-YFPQL GJIC assay is low in another
cell type, extending the assay time can improve the per-
formance, as shown in Fig. 4b. To our knowledge, iodide
is not an important intracellular signalling molecule like
Ca2+. Although using iodide might be a drawback of this
assay, it actually reduces the chance of false-positives.
Signal generators in the donor cells, adrenergic α1 recep-
tor or TrpV1, of the Ca2+-aequorin assay and SLC26A4
in I−-YFPQL assay can be affected by other chemicals,
which creates the potential for false-positives. Cellular
calcium signals have numerous targets and modulators,
but, to date, no SLC26A4 modulators have been re-
ported. Aequorin and YFPQL sensors in acceptor cells
are also pseudo-sources of false-positive results. The
Ca2+-aequorin and I−-YFPQL GJIC assays are com-
pared in Table 1.
The I−-YFPQL assay has the same limitations as other
GJIC assays. False positives are possible, as are chemicals
that do not affect GJIC activity but do change the YFP
quenching rate. All GJ-inhibiting hits obtained from this
assay must be confirmed to not inhibit SLC26A4.
Cells expressing both SLC26A4 and YFPQL (i.e.,
LN215-I−-YFPQL) can be used for this determination.
Chemicals that weaken the YFP quenching by iodide
in the cells act as false positives. All detected GJ acti-
vators must be confirmed to not enhance YFPQL
quenching by iodide when acceptor cells are plated
alone. The Ca2+-aequorin assay can also be used as a
second screening method to confirm positive results.
In theory, the I−-YFPQL assay can measure the activity
of any intercellular channels that allow the diffusion of
iodide, despite their composition. Although pannexins
have sequence homologies with innexins, the inverte-
brate GJ proteins, they have not been confirmed to form
GJs [21]. A recent report by Sahu et al. showed that the
formation of GJs by pannexins depends on cell type [22].
Undocked pannexin hemichannels were blocked by
treatment with 30 μM CBX, but pannexin GJs were not.
Thus, even if pannexin GJs exist in LN215 cells, the GJ
inhibition by CBX observed in the present report was
not due to the inhibition of pannexins.
We used lentiviral vectors to produce donor and ac-
ceptor cells in this study. An I−-YFPQL GJIC assay sys-
tem can be set up with other types of cells with
functional GJs, by transducing the cells with the two
viral vectors followed by antibiotic selection to create
donor and acceptor cells. Because lentivirus integrates
its genome into the host cell chromosomes with its inte-
grase, most transduced cells express the transgenes sta-
bly. Thus, this system is easy to apply to other cell types.
Cells that are impermeable to iodide are ideal for use in
the proposed GJIC assay. If a cell line shows sufficiently
greater YFPQL quenching by iodide when donor and ac-
ceptor cells are mixed and plated than when only
Fig. 5 Application of this assay system to HOS cells. HOS-I− and
HOS-YFPQL cells were mixed at a 2:1 ratio and plated on a 96-well
plate. After 24 h of incubation, the medium was changed to
C-solution containing vehicle or 25 μM CBX, followed by further
incubation for 10 min before the 10-s I−-YFP assay. The percent
YFP quenching at 10 s was plotted against for each well. Z’ factor
was calculated as described in the Methods section and shown in
the graph
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acceptor cells are plated, it can also be regarded as suit-
able for this GJIC assay.
Conclusions
We developed a new GJIC assay for HTS, which detects
iodide diffusion through GJs. The only materials needed
for this assay are donor and acceptor cells, a multi-plate
reader capable of fluorometry and automated injection,
C-solution, and I-solution. No dyes or reagents to read
luminescence or to generate a calcium signal are needed.
Each assay can be performed in 10 s. When this system
was used in LN215 human glioma cells and HOS human
osteosarcoma cells, the Z’ factors were over 0.7. This
assay is predicted to have a lower false-positive rate than
that of the Ca2+-aequorin assay. Thus, this assay is ap-




LN215 human glioma cells (a kind gift from Dr. Erwin
G. Van Meir), HOS human osteosarcoma cells (ATCC),
and HEK293T cells (ATCC) were cultured in Dulbecco’s
modified Eagle Medium (DMEM) containing 100 IU/ml
penicillin, 100 μg/ml streptomycin, and 10 % fetal bovine
serum. All cultures were maintained in humidified 5 %
CO2/95 % air at 37 °C. Ethical approval or consent to
the use of the cells used in this study is not required.
Plasmid construction
The lentiviral plasmid expressing YFPQL, pLVX-EIP-
YFPQL, was constructed by inserting a DNA fragment
encoding YFPQL into pLVX-EF1α-IRES-Puro purchased
from Clontech. The YFPQL fragment was prepared by
a NheI/XbaI digestion of pcDNA3.1/Hygro(+)-YFP-
H148Q/I152L (a kind gift from Wan Namkung) and
inserted in the SpeI site of the backbone plasmid.
To construct the lentiviral plasmid expressing
SLC26A4, an empty lentiviral vector, pLenti6P, was gen-
erated, and SLC26A4 was inserted. The construction
procedures are described below. A blunted woodchuck
posttranscriptional regulatory element (WPRE) was pre-
pared by ClaI digestion of pSUB/AM-CBA-EGFP-
WPRE-bGH [23] and subsequent blunting with Klenow
fragment. The blunted WPRE was inserted at the
blunted NsiI site of pLKO.1puro (Sigma). The resulting
plasmid, pLKO-W, had puromycin acetyltransferase
(PAC) linked to WPRE. A lentiviral plasmid from Life
Technologies, pLenti6/V5-GW/LacZ, was modified by
EcoRV digestion followed by self-ligation, and the prod-
uct was named pLenti6. A PAC-WPRE fragment with
5’-blunt and 3’-KpnI was prepared from pLKO-W by
sequential BamHI digestion, blunting, and KpnI diges-
tion. This PAC-WPRE fragment was inserted at a
SmaI/KpnI site of pLenti6, leading to an empty vector,
pLenti6P, that expressed PAC as a selection marker and
contained WPRE to enhance transgene expression.
SLC26A4 was removed from pcDNA3.1(+)-hSLC26A4
(a kind gift from Min Goo Lee) by NheI/XbaI diges-
tion and inserted at the XbaI site of pLenti6P.
Lentivirus production
HEK293T cells were plated on six-well plates at a density
of 4 * 105 cells/well and incubated for 24 h. Lentiviral
plasmid, psPAX2, and pMD2.G were mixed at a ratio of
4:3:1, and 3 μg of the mixture was transfected into
HEK293T cells with Lipofectamine2000 (Invitrogen) for
15 h. Cultures were refreshed with 2 mL of growth
media and cultivated for another 36 h. Media containing
lentivirus was harvested and cleared by centrifugation at
3000 rpm for 3 min before storage at −80 °C.
Lentiviral transduction and selection
LN215 and HOS cells were plated on a 24-well plate at
30 % confluence. After 24 h, the cells were transduced
with 400 μL of a 1:1 mixture of lentivirus and fresh
growth medium supplemented with 4 μg/mL polybrene
(Sigma) for 15 h before media change. Cells were further
incubated for 72 h and detached to be re-plated on six-
well plates with 2 μg/mL puromycin. After a week of
puromycin selection, cells were used for the GJIC assay.
Table 1 Comparison of the Ca2+-aequorin assay and I−-YFPQL assay
Ca2+-aequorin assay [18] I−-YFPQL assay (this report)
Signal Luminescence Fluorescence
Reagent needed for assay Coelenterazine None
Assay time (sec per well) 40 10 Longer assay time increases Z’ factor.
Measuring physiologic event? Yes (Ca2+) No (I−)
Sources of false positives ● Adrenergic α1 receptor or TrpV1 channel in donor cells ● SLC26A4
● Any target affecting cellular calcium ● Any target increasing cellular permeability to I−
● Aequorin ● YFPQL
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I−-YFPQL GJIC assay
Donor and receptor cells were detached with trypsin,
counted, mixed, and plated on 96-well plates. After 24 h
of incubation, culture media were changed to 100 μL of
C-solution (10 mM HEPES, pH 7.4, 140 mM NaCl,
10 mM glucose, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2).
Vehicle or 25 μM CBX was used to treat cultures for
10 min when drug treatment was indicated. The GJIC
assay was performed well by well. The fluorescence of
each well was measured with a POLARstar microplate
reader (BMG Labtech, Germany) every 0.4 s for the indi-
cated time. One second after the first measurement,
100 μL of I-solution (10 mM HEPES, pH 7.4, 140 mM
NaI, 10 mM glucose, 5 mM KCl, 1 mM MgCl2, 1 mM
CaCl2) was added via the injector in the plate reader.
The percent YFPQL fluorescence to time zero was calcu-
lated. The YFPQL quenching rate at a selected time point
reflected GJ activity.
Calculation of Z’ factor
Z’ factor has been used as a quality indicator of HTS sys-
tems [17]. Z’ factor was calculated as follows:







where σ and μ represent standard deviation and mean,
respectively, and c + and c- are the positive and negative
controls.
Additional files
Additional file 1: Expression of connexin43 in LN215 and HOS cells.
To determine whether LN215 and HOS cells express a major connexin,
connexin43, we performed immunoblot analysis with anti-connexin43
antibody (C13720, Transduction Laboratories). HeLa, LN215 and HOS cells
were lysed with PBS containing 1 % Triton X-100 and cOmplete™
protease inhibitor cocktail (Roche) before centrifugation at 15,000 × g
for 10 min at 4 °C. After the BCA protein assay, 20 μg of protein was
used for immunoblotting. Since HeLa cells do not express connexin43 [24],
they were used as a negative control. Connexin43 (arrow head) was
detected in LN215 and HOS lysates. (TIFF 271 kb)
Additional file 2: Determination of the optimal ratio of donor and
acceptor cells. This is the raw data (fluorescence intensity reads) in
Fig. 3a (Microsoft Excel format). (XLS 51 kb)
Additional file 3: Determination of the optimal ratio of donor and
acceptor cells. This is another presentation of the data in Fig. 3a. The
fluorescence intensity reads from the seven groups were presented in
individual graphs without normalization or background subtraction. Final
quenching rates were also shown. Rapid fluorescence reduction before
2 s was due to media dilution by added I-solution. (TIFF 1223 kb)
Additional file 4: Effect of CBX on YFP quenching when only
LN215-YFPQL cells were plated. Only LN215-YFPQL cells or a 2:1 mixture
of LN215-I− and LN215-YFPQL cells were plated on 96-well plate 24 h
before treatment with vehicle or 25 μM CBX for 10 min. Each treatment was
added to three wells. The I−-YFPQL assay was performed for 10 s. The
mean % YFP fluorescence ± standard deviation was plotted against
time. (TIFF 289 kb)
Additional file 5: List of chemicals tested in this study. (TIFF 397 kb)
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